- Home
- NRGV vs STXS Comparison
NRGV vs STXS Comparison
Compare NRGV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- STXS
- Stock Information
- Founded
- NRGV 2017
- STXS 1990
- Country
- NRGV United States
- STXS United States
- Employees
- NRGV N/A
- STXS N/A
- Industry
- NRGV Industrial Machinery/Components
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NRGV Miscellaneous
- STXS Health Care
- Exchange
- NRGV Nasdaq
- STXS Nasdaq
- Market Cap
- NRGV 133.4M
- STXS 151.3M
- IPO Year
- NRGV N/A
- STXS 2004
- Fundamental
- Price
- NRGV $1.48
- STXS $2.74
- Analyst Decision
- NRGV Buy
- STXS
- Analyst Count
- NRGV 3
- STXS 0
- Target Price
- NRGV $1.58
- STXS N/A
- AVG Volume (30 Days)
- NRGV 2.7M
- STXS 792.6K
- Earning Date
- NRGV 08-07-2025
- STXS 08-07-2025
- Dividend Yield
- NRGV N/A
- STXS N/A
- EPS Growth
- NRGV N/A
- STXS N/A
- EPS
- NRGV N/A
- STXS N/A
- Revenue
- NRGV $51,716,000.00
- STXS $31,806,000.00
- Revenue This Year
- NRGV $356.46
- STXS $29.03
- Revenue Next Year
- NRGV $34.31
- STXS $44.05
- P/E Ratio
- NRGV N/A
- STXS N/A
- Revenue Growth
- NRGV N/A
- STXS 33.94
- 52 Week Low
- NRGV $0.60
- STXS $1.54
- 52 Week High
- NRGV $2.70
- STXS $2.96
- Technical
- Relative Strength Index (RSI)
- NRGV 66.61
- STXS 63.17
- Support Level
- NRGV $1.34
- STXS $2.18
- Resistance Level
- NRGV $1.60
- STXS $2.96
- Average True Range (ATR)
- NRGV 0.17
- STXS 0.16
- MACD
- NRGV 0.03
- STXS 0.05
- Stochastic Oscillator
- NRGV 68.66
- STXS 74.12
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.